Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net loss	$ (30,588)	$ (8,331)
Denominator:
Weighted average Class A common share outstanding-basic	23,817	19,534
Weighted average Class A common share outstanding-diluted	23,817	19,534
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-basic	$ (1.28)	$ (0.43)
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-diluted	$ (1.28)	$ (0.43)
Common Class A [Member]
Numerator:
Net loss	$ (30,588)	$ (8,331)
Denominator:
Weighted average Class A common share outstanding-basic	23,817	19,534
Weighted average Class A common share outstanding-diluted	23,817	19,534
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-basic	$ (1.28)	$ (0.43)
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-diluted	$ (1.28)	$ (0.43)